|
HY-153383-50mg
|
MedChemexpress LLC
|
PDCD4-IN-1 [CAS 494763-64-3]
|
|
|
|
|
HY-153740-10mg
|
MedChemexpress LLC
|
PF-07284892 [CAS 2498597-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-153740-100mg
|
MedChemexpress LLC
|
PF-07284892 [CAS 2498597-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-153740-5mg
|
MedChemexpress LLC
|
PF-07284892 [CAS 2498597-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-153740-50mg
|
MedChemexpress LLC
|
PF-07284892 [CAS 2498597-94-5]
|
|
Cancer-Kinase/protease
|
|
|
HY-19999A-10mg
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-19999A-100mg
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-19999A-25mg
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-19999A-5mg
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-19999A-50mg
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-19999A-1mL
|
MedChemexpress LLC
|
PF-CBP1 hydrochloride [CAS 2070014-93-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-47888-10mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-47888-100mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-47888-25mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-47888-5mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-47888-50mg
|
MedChemexpress LLC
|
PLN-1474 [CAS 2408065-32-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-133131-1mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
|
HY-133131-10mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
|
HY-133131-25mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
|
HY-133131-5mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
|
HY-133131-50mg
|
MedChemexpress LLC
|
PROTAC BRD4 Degrader-1 [CAS 2133360-00-4]
|
|
Cancer-programmed cell death
|
|
|
HY-155978-1mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
|
HY-155978-10mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
|
HY-155978-25mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
|
HY-155978-5mg
|
MedChemexpress LLC
|
RDN2150 [CAS 2839429-51-3]
|
|
|
|
